Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Aerpace Industries Share Price
48.83+7.99 (+19.56%)
+131.64% past 1 Year
News
Amrutanjan Reports Stronger Q2 EBITDA Growth And Margin Expansion
Equity
AMRUTANJAN
Amrutanjan Healthcare Reports Stronger Second Quarter Net Profit Growth
Equity
AMRUTANJAN
Amrutanjan Q2 Revenue Rises To Rs 135 Crores From Rs 118 Crores
Equity
AMRUTANJAN
Shalby Reports Stable Q2 EBITDA Amid Year On Year Margin Compression
Equity
SHALBY
Shalby Reports Marginal Year on Year Decline In Q2 Consolidated Net Profit
Equity
SHALBY
Shalby Reports Stronger Second Quarter Revenue Growth Year on Year
Equity
SHALBY
Sandur Manganese Reports Stronger Second Quarter EBITDA and Margin
Equity
SANDUMA
Sandur Manganese Q2 Consolidated Net Profit Rises 86 Percent Year On Year
Equity
SANDUMA
Sandur Manganese Q2 Revenue Rises 22.4 Percent Year On Year
Equity
SANDUMA
NephroPlus Reports Q2 Net Profit After Prior Year Loss
Equity
NEPHROPLUS
NephroPlus Reports Strong Second Quarter Revenue Growth Year On Year
Equity
NEPHROPLUS
Anthem Biosciences Reports Stronger Second Quarter EBITDA And Margin
Equity
ANTHEM
Anthem Biosciences Reports Year On Year Growth In Second Quarter Net Profit
Equity
ANTHEM
Anthem Biosciences Reports Higher Second Quarter Revenue Growth
Equity
ANTHEM
NSE Reports Strong Second Quarter EBITDA Growth And Margin Expansion
Equity
NSE
NSE Reports Sharp Decline In Second Quarter Consolidated Net Profit
Equity
NSE
NSE Reports Second Quarter Revenue Growth Of 10.6 Percent Year On Year
Equity
NSE
Bata India Reports Higher Second Quarter Net Profit
Equity
BATAINDIA
Bata India reports strong second quarter revenue growth
Equity
BATAINDIA
Amanta Reports Strong Year On Year Growth In Second Quarter Net Profit
Equity
AMANTA